Rare diseases
Investigational molecules
Locations
1800 Owens Street Suite C1200, 94158-2584, United States
Eidos Therapeutics Inc. focuses on clinical research in symptomatic transthyretin amyloid cardiomyopathy, with attention to disease control, cardiac function, and the safety and tolerability of acoramidis in people living with established ATTR-CM.
The sponsor also supports longer-term clinical follow-up in newly diagnosed patients, reflecting continued interest in the management of progressive amyloid-related heart disease.
Eidos Therapeutics Inc. runs clinical trials in conditions such as Acquired ATTR amyloidosis, Cardiac amyloidosis, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Belgium
DenmarkBelgiumBelgiumIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
